These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 232020)

  • 1. A novel orally active converting-enzyme inhibitor YS 980: effects on blood pressure in spontaneously hypertensive rats.
    Unger T; Rockhold RW; Schaz K; Vescel P; Bönner G; Rascher W; Ganten D
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():157s-160s. PubMed ID: 232020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SA446, a new orally active converting enzyme inhibitor: antihypertensive action and comparison with captopril in stroke-prone spontaneously hypersensitive rats.
    Unger T; Yukimura T; Marin-Grez M; Lang RE; Rascher W; Ganten D
    Eur J Pharmacol; 1982 Mar; 78(4):411-20. PubMed ID: 6281036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive effects of the novel converting-enzyme inhibitor YS 980 in spontaneously hypertensive rats.
    Unger T; Rockhold RW; Bönner G; Rascher W; Schaz K; Speck G; Schömig A; Ganten D
    Clin Exp Hypertens (1978); 1981; 3(1):121-40. PubMed ID: 6258887
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of YS-980, an orally active converting enzyme inhibitor, on blood pressure in normotensive and hypertensive rats.
    Komori T; Yamamoto K
    Jpn J Pharmacol; 1981 Jun; 31(3):401-7. PubMed ID: 6273629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sodium loading on antihypertensive responses to an angiotensin-converting enzyme inhibitor in spontaneously hypertensive and renal hypertensive rats.
    Nakata K; Takada T; Yamauchi H; Iso T
    Eur J Pharmacol; 1986 Feb; 121(2):293-5. PubMed ID: 3009208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of an orally active converting enzyme inhibitor (YS-980) on renal function in dogs.
    Abe Y; Miura K; Imanishi M; Yukimura T; Komori T; Okahara T; Yamamoto K
    J Pharmacol Exp Ther; 1980 Jul; 214(1):166-70. PubMed ID: 6156237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitor of angiotensin I converting enzyme: (4R)-3-[(2S)-3-mercapto-2-methylpropanoyl]-4-thiazolidinecarboxylic acid (YS-980).
    Funae Y; Komori T; Sasaki D; Yamamoto K
    Biochem Pharmacol; 1980 Jun; 29(11):1543-7. PubMed ID: 6249321
    [No Abstract]   [Full Text] [Related]  

  • 8. Responses of the kallikrein-kinin system to angiotensin converting enzyme inhibitors in the rat.
    Yasujima M; Abe K; Tanno M; Omata K; Yoshinaga K
    Jpn Circ J; 1984 Feb; 48(2):173-9. PubMed ID: 6321815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on mechanisms of antinephritic action of SA-446 an angiotensin I converting enzyme inhibitor (1). A comparison with actions of spironolactone, kallidinogenase and saralasin.
    Suzuki Y; Ito M; Saito N
    Jpn J Pharmacol; 1986 Dec; 42(4):465-75. PubMed ID: 3027437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypotensive effect of SA446, an angiotensin converting enzyme inhibitor, in 2-kidney, 1-clip renal hypertensive and normotensive dogs.
    Nishimura K; Miyazaki M; Okunishi H; Toda N
    Jpn J Pharmacol; 1987 Apr; 43(4):379-87. PubMed ID: 3039218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of an angiotensin-converting enzyme (ACE) inhibitor, SA446, on tissue ACE activity in normotensive, spontaneously hypertensive, and renal hypertensive rats.
    Nakata K; Nishimura K; Takada T; Ikuse T; Yamauchi H; Iso T
    J Cardiovasc Pharmacol; 1987 Mar; 9(3):305-10. PubMed ID: 2437397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is tissue converting enzyme inhibition a determinant of the antihypertensive efficacy of converting enzyme inhibitors? Studies with the two different compounds, Hoe498 and MK421, in spontaneously hypertensive rats.
    Unger T; Ganten D; Lang RE; Schölkens BA
    J Cardiovasc Pharmacol; 1984; 6(5):872-80. PubMed ID: 6209494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal kallikrein-kinin system and the depressor effect of angiotensin converting enzyme inhibitors MK 421, SA 446, and captopril in rats.
    Yasujima M; Abe K; Kasai Y; Tanno M; Tajima J; Seino M; Chiba S; Sato K; Goto T; Omata K
    Clin Exp Hypertens A; 1984; 6(6):1207-25. PubMed ID: 6086184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of alacepril on renin-angiotensin-aldosterone system and kallikrein-kinin-prostaglandin system in experimental animals.
    Hosoki K; Takeyama K; Minato H; Fukuya F; Kawahara S; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):77-83. PubMed ID: 3006712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new potent inhibitor of converting enzyme: (2R,4R)-2-(2-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarboxylic acid(SA446).
    Iso T; Yamauchi H; Suda H; Nakata K; Nishimura K; Iwao J
    Jpn J Pharmacol; 1981 Dec; 31(6):875-82. PubMed ID: 6174764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiating mechanism of bradykinin action on smooth muscle by sulfhydryl compounds.
    Iso T; Nishimura K; Oya M; Iwao J
    Eur J Pharmacol; 1979 Mar; 54(3):303-5. PubMed ID: 428428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of converting enzyme inhibitors on renin-angiotensin system in normal rats.
    Komori T; Takada T; Funae Y; Yamamoto K
    Osaka City Med J; 1984 Jun; 30(1):17-30. PubMed ID: 6096787
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of angiotensin I-converting enzyme inhibitor (SA-446) on renal function in dogs.
    Takada T; Yamamoto K; Fujioka S; Tamaki T; Fukui K; Abe Y
    Jpn J Pharmacol; 1985 Jun; 38(2):227-30. PubMed ID: 2993720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo comparison of three orally active inhibitors of angiotensin-converting enzyme.
    DiNicolantonio R; Dinicolantonio R; Hutchinson JS; Mendelsohn FA; Doyle AE
    Am J Cardiol; 1982 Apr; 49(6):1502-4. PubMed ID: 6280478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of three different kininase II inhibitors on blood pressure and renal vasoactive substances in essential hypertensives.
    Abe K; Tajima J; Omata K; Tanno M; Tsunoda K; Kudo K; Onoda Y; Kohzuki M; Sasaki S; Takeuchi K
    Adv Exp Med Biol; 1986; 198 Pt B():269-77. PubMed ID: 3028076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.